Delivery of leptin to breast cancer cells enhances the proliferation rate through the activation of the STAT3 and ERK1/2 signaling pathway and diminishes apoptosis through a significant reduction in p53 expression and Bax production [24,25]. This evidence concerns the gene STAT3 and breast carcinoma.